HRT FINANCIAL LP - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 61 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$7,000
+40.0%
27,034
+170.3%
0.00%
Q4 2021$5,000
-97.8%
10,000
-95.5%
0.00%
-100.0%
Q3 2021$227,000
-42.7%
222,751
-22.4%
0.00%
-75.0%
Q2 2021$396,000
+296.0%
286,963
+502.0%
0.00%0.0%
Q4 2019$100,000
+88.7%
47,666
+198.1%
0.00%
-78.9%
Q2 2018$53,00015,9900.02%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
LINCOLN CAPITAL CORP 62,000$216,0000.20%
Monashee Investment Management LLC 187,190$651,0000.15%
Cedar Wealth Management, LLC 46,395$161,0000.10%
BCWM, LLC 35,100$122,0000.06%
Tibra Equities Europe Ltd 149,595$521,0000.05%
Ahrens Investment Partners LLC 30,900$108,0000.05%
ExodusPoint Capital Management, LP 151,904$529,0000.04%
Laurion Capital Management LP 833,400$2,900,0000.04%
Alpine Global Management, LLC 33,928$118,0000.03%
Cornerstone Capital, Inc. 57,550$200,0000.03%
View complete list of ACELRX PHARMACEUTICALS INC shareholders